TIMOTHY MARTINDALE: Open Payments
NPI 1003824632 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,190 in 100 payments from 24 companies in 2025. Trend: 2023 $1,955 · 2024 $1,859 · 2025 $2,190
Food & beverage: $2,023Education: $167
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 13 | $365 |
| Kowa Pharmaceuticals America, Inc. | 16 | $347 |
| Lilly USA, LLC | 9 | $241 |
| Astellas Pharma US Inc | 3 | $171 |
| Amgen Inc. | 21 | $169 |
| Boston Scientific Corporation | 1 | $149 |
| Otsuka America Pharmaceutical, Inc. | 7 | $148 |
| Novo Nordisk Inc | 6 | $116 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
Products named: ZORYVE, Axonics, REXULTI, KISUNLA, Epclusa, JARDIANCE, OTEZLA, EVENITY.
Industry payments across TX — which companies pay providers there.
